SCHEMBL2532841

SCHEMBL2532841

COC(=O)c1ccc2c(c1)CC(C)(C)C(c1ccccc1NC(=O)C1CC1)N2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
ALDH1A1 P00352 5/20 0.48
HPGD P15428 2/20 0.45
CYP3A4 P08684 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP1A2 P05177 1/20 0.45
HSD17B10 Q99714 4/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 2/20 0.38
GSK3B P49841 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2534787 0.96 ALDH1A1 (0.45) KDM4EALDH1A1HPGDCYP3A4MAPT
SCHEMBL2532897 0.90 GCK (0.38) KDM4EALDH1A1HPGDCYP3A4MAPT
SCHEMBL2530120 0.86 ALDH1A1 (0.41) KDM4EALDH1A1HPGDHSD17B10NPSR1
SCHEMBL15509501 0.84 GAA (0.39) KDM4EALDH1A1HPGDHSD17B10NPSR1
SCHEMBL2533627 0.83 SMN1; SMN2 (0.44) KDM4EALDH1A1HPGDCYP3A4MEN1
SCHEMBL2534274 0.83 NPC1 (0.40) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL2536690 0.82 ALDH1A1 (0.46) KDM4EALDH1A1HPGDCYP3A4MAPT
SCHEMBL2533620 0.82 HSD17B10 (0.44) KDM4EALDH1A1HPGDCYP3A4MAPT
SCHEMBL2533560 0.82 ALDH1A1 (0.39) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL2537969 0.81 CYP2C9 (0.46) KDM4EALDH1A1HPGDCYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 KDM4E 796/4885ALDH1A1 552/4885HPGD 1640/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 KDM4E 796/4885ALDH1A1 552/4885HPGD 1640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.